Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Youngmin Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5517-3396; OpenAlex author ID A5006870880. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 4

  1. Correction: Evaluating Tumor Regression and Survival Outcomes in Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment according to CAP Grading System: … Co-author DOI 10.1245/s10434-026-20624-1↗
  2. Efficacy of Neoadjuvant Radiotherapy After Chemotherapy and the Optimal Interval from Radiotherapy to Surgery for Borderline Resectable and Resectable Pancreat… Co-author DOI 10.1245/s10434-024-16743-2↗
  3. Evaluating Tumor Regression and Survival Outcomes in Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment according to CAP Grading System: Clinical Use… Co-author DOI 10.1245/s10434-025-18123-w↗
  4. Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: metabolite genomewide association study based on the KCPS-II cohort. Co-author DOI 10.1186/s12967-023-04670-x↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hye‐Sol Jung · 3 shared papers, 2025–2026 · strength 0.76
  2. Won‐Gun Yun · 3 shared papers, 2025–2026 · strength 0.76
  3. Yoon Soo Chae · 3 shared papers, 2025–2026 · strength 0.76
  4. Jin‐Young Jang · 3 shared papers, 2025–2026 · strength 0.76
  5. Wooil Kwon · 3 shared papers, 2025–2026 · strength 0.76
  6. Go‐Won Choi · 2 shared papers, 2025–2026 · strength 0.52
  7. Younsoo Seo · 2 shared papers, 2025–2026 · strength 0.52
  8. Joon Seong Park · 2 shared papers, 2025 · strength 0.48
  9. Eui Kyu Chie · 1 shared paper, 2025 · strength 0.25
  10. Sun Ha Jee · 1 shared paper, 2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.